المؤلفون: 郭明良

المساهمون: 國立臺灣大學醫學院毒理學研究所

مصطلحات موضوعية: 癌轉移, 淋巴管新生, C 型血管內皮生長因子, 血管內皮生長因子受體3 號, 激脢受體活化酵素連結免疫吸附分析法, Metastasis, Lymphangiogenesis, VEGF-C, VEGF -D, VEGFR-3 KIRA-ELISA

جغرافية الموضوع: 計畫年度：93, 起迄日期：2004-08-01/2005-07-31

وصف الملف: application/pdf; 470993 bytes

Relation: 932323B002007; http://ntur.lib.ntu.edu.tw/handle/246246/25834; http://ntur.lib.ntu.edu.tw/bitstream/246246/25834/1/932323B002007.pdf

الاتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/25834
http://ntur.lib.ntu.edu.tw/bitstream/246246/25834/1/932323B002007.pdf

المؤلفون: 蘇振良, Su, Jen-Liang

المساهمون: 郭明良, 臺灣大學：毒理學研究所

مصطلحات موضوعية: 血管內皮生長因子受體3號, C型血管內皮生長因子, 第二型環氧化酵素, 細胞黏著分子, 癌轉移, 訊息傳遞, 淋巴管新生, invasion, VEGF receptor-3, vascular endothelial growth factor–C, cyclooxygenase-2, metastasis, contactin-1, lymphangiogenesis

وصف الملف: 5666115 bytes; application/pdf

Relation: References 1. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol, 77: 123-136, 1982. 2. Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K., and Stacker, S. A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A, 95: 548-553, 1998. 3. Akagi, K., Ikeda, Y., Miyazaki, M., Abe, T., Kinoshita, J., Maehara, Y., and Sugimachi, K. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer, 83: 887-891, 2000. 4. Albanell, J., Codony-Servat, J., Rojo, F., Del Campo, J. M., Sauleda, S., Anido, J., Raspall, G., Giralt, J., Rosello, J., Nicholson, R. I., Mendelsohn, J., and Baselga, J. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res, 61: 6500-6510, 2001. 5. Alitalo, K. and Carmeliet, P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell, 1: 219-227, 2002. 6. Anthony, T. L., Lindsey, J. D., Aihara, M., and Weinreb, R. N. Detection of prostaglandin EP(1), EP(2), and FP receptor subtypes in human sclera. Invest Ophthalmol Vis Sci, 42: 3182-3186, 2001. 7. Aprelikova, O., Pajusola, K., Partanen, J., Armstrong, E., Alitalo, R., Bailey, S. K., McMahon, J., Wasmuth, J., Huebner, K., and Alitalo, K. FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res, 52: 746-748, 1992. 8. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M., and Jackson, D. G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol, 144: 789-801, 1999. 9. Bedogni, B., O'Neill, M. S., Welford, S. M., Bouley, D. M., Giaccia, A. J., Denko, N. C., and Powell, M. B. Topical treatment with inhibitors of the phosphatidylinositol 3'-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice. Cancer Res, 64: 2552-2560, 2004. 10. Beierle, E. A., Dai, W., Langham, M. R., Jr., Copeland, E. M., 3rd, and Chen, M. K. VEGF receptors are differentially expressed by neuroblastoma cells in culture. J Pediatr Surg, 38: 514-521, 2003. 11. Beltran, P. J. and Bixby, J. L. Receptor protein tyrosine phosphatases as mediators of cellular adhesion. Front Biosci, 8: d87-99, 2003. 12. Brinson, A. E., Harding, T., Diliberto, P. A., He, Y., Li, X., Hunter, D., Herman, B., Earp, H. S., and Graves, L. M. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. Dependence on calcium and the actin cytoskeleton. J Biol Chem, 273: 1711-1718, 1998. 13. Byzova, T. V., Goldman, C. K., Pampori, N., Thomas, K. A., Bett, A., Shattil, S. J., and Plow, E. F. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell, 6: 851-860, 2000. 14. Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J. H., Claesson-Welsh, L., and Alitalo, K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A, 95: 14389-14394, 1998. 15. Chambers, A. F., Groom, A. C., and MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2: 563-572, 2002. 16. Chen, J. J., Peck, K., Hong, T. M., Yang, S. C., Sher, Y. P., Shih, J. Y., Wu, R., Cheng, J. L., Roffler, S. R., Wu, C. W., and Yang, P. C. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res, 61: 5223-5230, 2001. 17. Chu, Y. W., Yang, P. C., Yang, S. C., Shyu, Y. C., Hendrix, M. J., Wu, R., and Wu, C. W. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol, 17: 353-360, 1997. 18. Chung, T. W., Lee, Y. C., and Kim, C. H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. Faseb J, 18: 1123-1125, 2004. 19. Darmoul, D., Gratio, V., Devaud, H., and Laburthe, M. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem, 279: 20927-20934, 2004. 20. Daub, H., Wallasch, C., Lankenau, A., Herrlich, A., and Ullrich, A. Signal characteristics of G protein-transactivated EGF receptor. Embo J, 16: 7032-7044, 1997. 21. Daub, H., Weiss, F. U., Wallasch, C., and Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature, 379: 557-560, 1996. 22. Dias, S., Choy, M., Alitalo, K., and Rafii, S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood, 99: 2179-2184, 2002. 23. Dias, S., Hattori, K., Heissig, B., Zhu, Z., Wu, Y., Witte, L., Hicklin, D. J., Tateno, M., Bohlen, P., Moore, M. A., and Rafii, S. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A, 98: 10857-10862, 2001. 24. Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., Wu, Y., Chadburn, A., Hyjek, E., Gill, M., Hicklin, D. J., Witte, L., Moore, M. A., and Rafii, S. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest, 106: 511-521, 2000. 25. Dikic, I., Tokiwa, G., Lev, S., Courtneidge, S. A., and Schlessinger, J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature, 383: 547-550, 1996. 26. Dohadwala, M., Batra, R. K., Luo, J., Lin, Y., Krysan, K., Pold, M., Sharma, S., and Dubinett, S. M. Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem, 277: 50828-50833, 2002. 27. Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., and Alitalo, K. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science, 282: 946-949, 1998. 28. Ebata, N., Nodasaka, Y., Sawa, Y., Yamaoka, Y., Makino, S., Totsuka, Y., and Yoshida, S. Desmoplakin as a specific marker of lymphatic vessels. Microvasc Res, 61: 40-48, 2001. 29. Faivre-Sarrailh, C., Falk, J., Pollerberg, E., Schachner, M., and Rougon, G. NrCAM, cerebellar granule cell receptor for the neuronal adhesion molecule F3, displays an actin-dependent mobility in growth cones. J Cell Sci, 112 Pt 18: 3015-3027, 1999. 30. Fidler, I. J. Critical determinants of metastasis. Semin Cancer Biol, 12: 89-96, 2002. 31. Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., Taketo, M. M., and Sugihara, K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res, 58: 4823-4826, 1998. 32. Galland, F., Karamysheva, A., Pebusque, M. J., Borg, J. P., Rottapel, R., Dubreuil, P., Rosnet, O., and Birnbaum, D. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene, 8: 1233-1240, 1993. 33. Gershenwald, J. E. and Fidler, I. J. Cancer. Targeting lymphatic metastasis. Science, 296: 1811-1812, 2002. 34. Girault, J. A. and Peles, E. Development of nodes of Ranvier. Curr Opin Neurobiol, 12: 476-485, 2002. 35. Gospodarowicz, D., Abraham, J. A., and Schilling, J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A, 86: 7311-7315, 1989. 36. Hansen-Petrik, M. B., McEntee, M. F., Jull, B., Shi, H., Zemel, M. B., and Whelan, J. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Cancer Res, 62: 403-408, 2002. 37. Hashimoto, I., Kodama, J., Seki, N., Hongo, A., Yoshinouchi, M., Okuda, H., and Kudo, T. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer, 85: 93-97, 2001. 38. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res, 58: 3761-3764, 1998. 39. Hong, T. M., Yang, P. C., Peck, K., Chen, J. J., Yang, S. C., Chen, Y. C., and Wu, C. W. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. Am J Respir Cell Mol Biol, 23: 355-363, 2000. 40. Howe, L. R., Subbaramaiah, K., Patel, J., Masferrer, J. L., Deora, A., Hudis, C., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M., and Dannenberg, A. J. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res, 62: 5405-5407, 2002. 41. Huang, J., Asawa, T., Takato, T., and Sakai, R. Cooperative roles of Fyn and cortactin in cell migration of metastatic murine melanoma. J Biol Chem, 278: 48367-48376, 2003. 42. Iwai, N., Martinez, A., Miller, M. J., Vos, M., Mulshine, J. L., and Treston, A. M. Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors. Lung Cancer, 23: 209-222, 1999. 43. Jain, R. K. and Fenton, B. T. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst, 94: 417-421, 2002. 44. Jain, R. K. and Padera, T. P. Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J Natl Cancer Inst, 94: 785-787, 2002. 45. Jiang, K., Sun, J., Cheng, J., Djeu, J. Y., Wei, S., and Sebti, S. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol Cell Biol, 24: 5565-5576, 2004. 46. Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., and Tarnawski, A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med, 5: 1418-1423, 1999. 47. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J, 15: 1751, 1996. 48. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., and Alitalo, K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A, 92: 3566-3570, 1995. 49. Karkkainen, M. J., Makinen, T., and Alitalo, K. Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol, 4: E2-5, 2002. 50. Karpanen, T. and Alitalo, K. Lymphatic vessels as targets of tumor therapy? J Exp Med, 194: F37-42, 2001. 51. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Yla-Herttuala, S., Jaattela, M., and Alitalo, K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res, 61: 1786-1790, 2001. 52. Katou, F., Ohtani, H., Saaristo, A., Nagura, H., and Motegi, K. Immunological activation of dermal Langerhans cells in contact with lymphocytes in a model of human inflamed skin. Am J Pathol, 156: 519-527, 2000. 53. Kijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B., Sattler, M., Johnson, B. E., and Salgia, R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res, 62: 6304-6311, 2002. 54. Kim, M. S., Lee, E. J., Kim, H. R., and Moon, A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res, 63: 5454-5461, 2003. 55. Kinoshita, J., Kitamura, K., Kabashima, A., Saeki, H., Tanaka, S., and Sugimachi, K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat, 66: 159-164, 2001. 56. Kozaki, K., Koshikawa, K., Tatematsu, Y., Miyaishi, O., Saito, H., Hida, T., Osada, H., and Takahashi, T. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene, 20: 4228-4234, 2001. 57. Krishnan, J., Kirkin, V., Steffen, A., Hegen, M., Weih, D., Tomarev, S., Wilting, J., and Sleeman, J. P. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res, 63: 713-722, 2003. 58. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., and Alitalo, K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 122: 3829-3837, 1996. 59. Kuratomi, Y., Nomizu, M., Nielsen, P. K., Tanaka, K., Song, S. Y., Kleinman, H. K., and Yamada, Y. Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain. Exp Cell Res, 249: 386-395, 1999. 60. Lai, J. P., Chien, J., Strome, S. E., Staub, J., Montoya, D. P., Greene, E. L., Smith, D. I., Roberts, L. R., and Shridhar, V. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene, 23: 1439-1447, 2004. 61. Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., and Wood, W. I. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci U S A, 93: 1988-1992, 1996. 62. Li, Q., Dong, X., Gu, W., Qiu, X., and Wang, E. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer. Chin Med J (Engl), 116: 727-730, 2003. 63. Lin, M. T., Lee, R. C., Yang, P. C., Ho, F. M., and Kuo, M. L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem, 276: 48997-49002, 2001. 64. Liu, B., Earl, H. M., Baban, D., Shoaibi, M., Fabra, A., Kerr, D. J., and Seymour, L. W. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun, 217: 721-727, 1995. 65. Liu, F., Verin, A. D., Wang, P., Day, R., Wersto, R. P., Chrest, F. J., English, D. K., and Garcia, J. G. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am J Respir Cell Mol Biol, 24: 711-719, 2001. 66. Luttrell, L. M., Daaka, Y., Della Rocca, G. J., and Lefkowitz, R. J. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem, 272: 31648-31656, 1997. 67. Ma, C., Lin, H., Leonard, S. S., Shi, X., Ye, J., and Luo, J. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro. Oncogene, 22: 5281-5290, 2003. 68. Ma, L., del Soldato, P., and Wallace, J. L. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance. Proc Natl Acad Sci U S A, 99: 13243-13247, 2002. 69. Makinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S., Yla-Herttuala, S., and Alitalo, K. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med, 7: 199-205, 2001. 70. Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E. C., Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D., Stacker, S. A., Achen, M. G., and Alitalo, K. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. Embo J, 20: 4762-4773, 2001. 71. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M. S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. Embo J, 20: 672-682, 2001. 72. Marchio, S., Primo, L., Pagano, M., Palestro, G., Albini, A., Veikkola, T., Cascone, I., Alitalo, K., and Bussolino, F. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem, 274: 27617-27622, 1999. 73. Masood, R., Kundra, A., Zhu, S., Xia, G., Scalia, P., Smith, D. L., and Gill, P. S. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer, 104: 603-610, 2003. 74. Mottet, D., Michel, G., Renard, P., Ninane, N., Raes, M., and Michiels, C. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol, 194: 30-44, 2003. 75. Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., Koteliansky, V., and Arteaga, C. L. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest, 109: 1551-1559, 2002. 76. Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., and Arteaga, C. L. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Mol Cell Biol, 23: 8691-8703, 2003. 77. Narumiya, S., Sugimoto, Y., and Ushikubi, F. Prostanoid receptors: structures, properties, and functions. Physiol Rev, 79: 1193-1226, 1999. 78. Neuchrist, C., Erovic, B. M., Handisurya, A., Fischer, M. B., Steiner, G. E., Hollemann, D., Gedlicka, C., Saaristo, A., and Burian, M. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck, 25: 464-474, 2003. 79. Olofsson, B., Jeltsch, M., Eriksson, U., and Alitalo, K. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol, 10: 528-535, 1999. 80. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996. 81. Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., and Tarnawski, A. S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med, 8: 289-293, 2002. 82. Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., and Alitalo, K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res, 52: 5738-5743, 1992. 83. Papoutsi, M., Siemeister, G., Weindel, K., Tomarev, S. I., Kurz, H., Schachtele, C., Martiny-Baron, G., Christ, B., Marme, D., and Wilting, J. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol, 114: 373-385, 2000. 84. Partanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., and Alitalo, K. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. Faseb J, 14: 2087-2096, 2000. 85. Pepper, M. S. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res, 7: 462-468, 2001. 86. Plate, K. From angiogenesis to lymphangiogenesis. Nat Med, 7: 151-152, 2001. 87. Podar, K., Catley, L. P., Tai, Y. T., Shringarpure, R., Carvalho, P., Hayashi, T., Burger, R., Schlossman, R. L., Richardson, P. G., Pandite, L. N., Kumar, R., Hideshima, T., Chauhan, D., and Anderson, K. C. GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironment. Blood, 103: 3474-3479, 2004. 88. Porter, A. C. and Vaillancourt, R. R. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene, 17: 1343-1352, 1998. 89. Price, D. J., Miralem, T., Jiang, S., Steinberg, R., and Avraham, H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ, 12: 129-135, 2001. 90. Reid, R. A., Bronson, D. D., Young, K. M., and Hemperly, J. J. Identification and characterization of the human cell adhesion molecule contactin. Brain Res Mol Brain Res, 21: 1-8, 1994. 91. Revest, J. M., Faivre-Sarrailh, C., Maeda, N., Noda, M., Schachner, M., and Rougon, G. The interaction between F3 immunoglobulin domains and protein tyrosine phosphatases zeta/beta triggers bidirectional signalling between neurons and glial cells. Eur J Neurosci, 11: 1134-1147, 1999. 92. Revest, J. M., Faivre-Sarrailh, C., Schachner, M., and Rougon, G. Bidirectional signaling between neurons and glial cells via the F3 neuronal adhesion molecule. Adv Exp Med Biol, 468: 309-318, 1999. 93. Rieger-Christ, K. M., Lee, P., Zagha, R., Kosakowski, M., Moinzadeh, A., Stoffel, J., Ben-Ze'ev, A., Libertino, J. A., and Summerhayes, I. C. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene, 23: 4745-4753, 2004. 94. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res, 57: 1276-1280, 1997. 95. Rodriguez-Niedenfuhr, M., Papoutsi, M., Christ, B., Nicolaides, K. H., von Kaisenberg, C. S., Tomarev, S. I., and Wilting, J. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl), 204: 399-406, 2001. 96. Rosenthal, A., Lindquist, P. B., Bringman, T. S., Goeddel, D. V., and Derynck, R. Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell, 46: 301-309, 1986. 97. Rozic, J. G., Chakraborty, C., and Lala, P. K. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer, 93: 497-506, 2001. 98. Saito, Y. and Berk, B. C. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol, 33: 3-7, 2001. 99. Sakurai, T., Lustig, M., Nativ, M., Hemperly, J. J., Schlessinger, J., Peles, E., and Grumet, M. Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. J Cell Biol, 136: 907-918, 1997. 100. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res, 55: 3785-3789, 1995. 101. Santos, S. C. and Dias, S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood, 103: 3883-3889, 2004. 102. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., and Kerjaschki, D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol, 161: 947-956, 2002. 103. Seno, H., Oshima, M., Ishikawa, T. O., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., and Taketo, M. M. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res, 62: 506-511, 2002. 104. Shih, J. Y., Yang, S. C., Hong, T. M., Yuan, A., Chen, J. J., Yu, C. J., Chang, Y. L., Lee, Y. C., Peck, K., Wu, C. W., and Yang, P. C. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst, 93: 1392-1400, 2001. 105. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med, 7: 192-198, 2001. 106. Sleeman, J. P. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res, 157: 55-81, 2000. 107. Song, I. H. [Cancer metastasis and metastasis suppressors]. Korean J Gastroenterol, 43: 1-7, 2004. 108. Stacker, S. A., Baldwin, M. E., and Achen, M. G. The role of tumor lymphangiogenesis in metastatic spread. Faseb J, 16: 922-934, 2002. 109. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med, 7: 186-191, 2001. 110. Steeg, P. S. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer, 3: 55-63, 2003. 111. Strizzi, L., Catalano, A., Vianale, G., Orecchia, S., Casalini, A., Tassi, G., Puntoni, R., Mutti, L., and Procopio, A. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol, 193: 468-475, 2001. 112. Su, J. L., Shih, J. Y., Yen, M. L., Jeng, Y. M., Chang, C. C., Hsieh, C. Y., Wei, L. H., Yang, P. C., and Kuo, M. L. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res, 64: 554-564, 2004. 113. Subbaramaiah, K., Norton, L., Gerald, W., and Dannenberg, A. J. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem, 277: 18649-18657, 2002. 114. Sun, Y., Tang, X. M., Half, E., Kuo, M. T., and Sinicrope, F. A. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res, 62: 6323-6328, 2002. 115. Suyama, K., Shapiro, I., Guttman, M., and Hazan, R. B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell, 2: 301-314, 2002. 116. Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., and Golub, T. R. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A, 96: 2907-2912, 1999. 117. Tanaka, S., Sugimachi, K., Kameyama, T., Maehara, S., Shirabe, K., Shimada, M., Wands, J. R., and Maehara, Y. Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology, 37: 1122-1129, 2003. 118. Tanaka, Y., Kobayashi, H., Suzuki, M., Kanayama, N., and Terao, T. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem, 279: 8567-8576, 2004. 119. Tang, Y., Zhang, D., Fallavollita, L., and Brodt, P. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res, 63: 1166-1171, 2003. 120. Tsai, P. W., Shiah, S. G., Lin, M. T., Wu, C. W., and Kuo, M. L. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem, 278: 5750-5759, 2003. 121. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A, 94: 3336-3340, 1997. 122. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998. 123. Umemori, H., Sato, S., Yagi, T., Aizawa, S., and Yamamoto, T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature, 367: 572-576, 1994. 124. Van Trappen, P. O., Gyselman, V. G., Lowe, D. G., Ryan, A., Oram, D. H., Bosze, P., Weekes, A. R., Shepherd, J. H., Dorudi, S., Bustin, S. A., and Jacobs, I. J. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet, 357: 15-20, 2001. 125. Van Trappen, P. O., Steele, D., Lowe, D. G., Baithun, S., Beasley, N., Thiele, W., Weich, H., Krishnan, J., Shepherd, J. H., Pepper, M. S., Jackson, D. G., Sleeman, J. P., and Jacobs, I. J. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol, 201: 544-554, 2003. 126. Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D. A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A, 91: 2046-2050, 1994. 127. Veikkola, T., Karkkainen, M., Claesson-Welsh, L., and Alitalo, K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res, 60: 203-212, 2000. 128. von Marschall, Z., Cramer, T., Hocker, M., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E. O., Wiedenmann, B., and Rosewicz, S. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology, 119: 1358-1372, 2000. 129. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 84: 1875-1887, 1992. 130. Weninger, W., Partanen, T. A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Pammer, J., Sturzl, M., Kerjaschki, D., Alitalo, K., and Tschachler, E. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest, 79: 243-251, 1999. 131. Wigle, J. T. and Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell, 98: 769-778, 1999. 132. Witmer, A. N., van Blijswijk, B. C., Dai, J., Hofman, P., Partanen, T. A., Vrensen, G. F., and Schlingemann, R. O. VEGFR-3 in adult angiogenesis. J Pathol, 195: 490-497, 2001. 133. Witte, D., Thomas, A., Ali, N., Carlson, N., and Younes, M. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res, 22: 1463-1466, 2002. 134. Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A. General mechanisms of metastasis. Cancer, 80: 1529-1537, 1997. 135. Wu, K. K. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol, 33: 179-207, 1995. 136. Wu, W., Shu, X., Hovsepyan, H., Mosteller, R. D., and Broek, D. VEGF receptor expression and signaling in human bladder tumors. Oncogene, 22: 3361-3370, 2003. 137. Yang, W., Klos, K., Yang, Y., Smith, T. L., Shi, D., and Yu, D. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer, 94: 2855-2861, 2002. 138. Yayon, A. and Klagsbrun, M. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cancer Metastasis Rev, 9: 191-202, 1990. 139. Yi, B., Williams, P. J., Niewolna, M., Wang, Y., and Yoneda, T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res, 62: 917-923, 2002. 140. Yonemura, Y., Fushida, S., Bando, E., Kinoshita, K., Miwa, K., Endo, Y., Sugiyama, K., Partanen, T., Yamamoto, H., and Sasaki, T. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer, 37: 918-923, 2001. 141. Yoshida, B. A., Sokoloff, M. M., Welch, D. R., and Rinker-Schaeffer, C. W. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst, 92: 1717-1730, 2000. 142. Zeng, L., D'Alessandri, L., Kalousek, M. B., Vaughan, L., and Pallen, C. J. Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J Cell Biol, 147: 707-714, 1999. 143. Zhao, W., Cavallaro, S., Gusev, P., and Alkon, D. L. Nonreceptor tyrosine protein kinase pp60c-src in spatial learning: synapse-specific changes in its gene expression, tyrosine phosphorylation, and protein-protein interactions. Proc Natl Acad Sci U S A, 97: 8098-8103, 2000. 144. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., and Schror, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res, 59: 198-204, 1999.; zh-TW; http://ntur.lib.ntu.edu.tw/handle/246246/63663; http://ntur.lib.ntu.edu.tw/bitstream/246246/63663/1/ntu-93-F88447004-1.pdf

الاتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/63663
http://ntur.lib.ntu.edu.tw/bitstream/246246/63663/1/ntu-93-F88447004-1.pdf

المؤلفون: 蘇振良(Jen-Liang Su)

المساهمون: 醫學院癌症生物學研究所, 中國附醫分子醫學中心生物醫學

مصطلحات موضوعية: C型血管內皮生長因子, 血管內皮生長因子受體3 號, 腫瘤發生進程, 化學治療敏感度, 放射線治療的敏感度

Relation: http://ir.cmu.edu.tw/ir/handle/310903500/12509; http://ir.cmu.edu.tw/ir/bitstream/310903500/12509/1/index.html

الاتاحة: http://ir.cmu.edu.tw/ir/handle/310903500/12509
http://ir.cmu.edu.tw/ir/bitstream/310903500/12509/1/index.html

المؤلفون: 蘇振良, 郭明良

المساهمون: 中國醫藥大學醫學研究所

مصطلحات موضوعية: C型血管內皮生長因子, 血管內皮生長因子受體3 號, 腫瘤發生進程, 化學治療敏感度, 放射線治療的敏感度

وصف الملف: 194 bytes; text/html

Relation: http://ir.cmu.edu.tw/ir/handle/310903500/25340; http://ir.cmu.edu.tw/ir/bitstream/310903500/25340/1/index.html

الاتاحة: http://ir.cmu.edu.tw/ir/handle/310903500/25340
http://ir.cmu.edu.tw/ir/bitstream/310903500/25340/1/index.html